Certain A Shares of Micro-Tech Co., LTD are subject to a Lock-Up Agreement Ending on 22-JUL-2022.
July 21, 2022
Share
Certain A Shares of Micro-Tech (Nanjing) Co., LTD are subject to a Lock-Up Agreement Ending on 22-JUL-2022. These A Shares will be under lockup for 1104 days starting from 14-JUL-2019 to 22-JUL-2022.
Details:
Nanjing New Micro-Enterprise Management Consulting Co., Ltd., Shenzhen Zhongke Merchants Venture Capital Co., Ltd., Huakang Limited, Shenzhen Huasheng Leading Equity Investment Partnership (Limited Partnership), Long Xiaohui, and Leng Derong promised that within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 months from listing, lock-up period will be automatically extended for another 6 months. After the expiry of the lock-up period (including the extended lock-up period), the parties promise that yearly transfer of shares made by them will not exceed 25% of the holding, both direct and indirect, held by the present parties.
Green Paper Investment Limited, Nanjing Maitai Investment Partnership (Limited Partnership), Pan Yajuan, Xu Xinggang, Zhang Tianbing's, Zhang Bo, and Yu Chen promised that within 12 months since the date of listing of the present shares in the Shenzhen Stock Exchange, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 months from listing, lock-up period will be automatically extended for another 6 months.
Micro-Tech Nanjing Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of minimally invasive medical devices. The Company's main products include three series of endoscopic diagnosis and treatment instruments used with endoscopes, microwave ablation equipment and consumables, and disposable endoscopes. Endoscopic diagnosis and treatment equipment mainly includes biopsy, hemostasis and closure, Endoscopic Mucosal Resection (EMR)/Endoscopic Submucosal Dissection (ESD), dilation, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS) and Endobronchial Ultrasound (EBUS) products. Microwave ablation mainly includes microwave ablation instrument and microwave ablation needle series products. Disposable endoscope mainly includes disposable biliopancreatic imaging system (choledochoscope) and related consumables and other products.